This marks a major step forward for the Laprixa team. Since summer 2024, we’ve been working hard to prepare this trial: assembling Laprixa Probes in the Medace BV cleanroom together with our partner AIM B.V., writing the clinical investigation plan, and arranging final verification and validation tests.

💡 Laprixa has already shown promising results in multiple pre-clinical tests, and a prior prototype tested in humans in a proof-of-principle study reached a predictive value of 89%. But this will be the first time the fully integrated Laprixa System, designed for laparoscopic (minimally invasive) surgery, will be used in a human clinical setting.

We’re excited to demonstrate the functionality and safety of Laprixa in a real-world clinical environment - and share our progress with you along the way.

👉 Follow us for more updates later this year!

hashtag#MedicalDevices hashtag#Innovation hashtag#ClinicalTrials hashtag#FirstInHuman hashtag#SurgicalInnovation hashtag#MedTech hashtag#Laprixa hashtag#MinimallyInvasiveSurgery